RAD21 and ovarian carcinoma: Previous studies have shown that RAD21 amplification epigenetically interacts with YAP/TEAD4 transcriptional co-repressors, recruiting the NuRD complex to inhibit interferon (IFN) signaling and promote immune evasion in ovarian cancer (11).